Literature DB >> 124159

Hemodynamics of the interposition mesocaval shunt.

T Drapanas, J LoCicero, J B Dowling.   

Abstract

Eighty interposition mesocaval shunts, using a knitted Dacron large diameter prosthesis, have been performed during the past five and one-half years. Patients were evaluated from the standpoint of protection from recurrent esophageal hemorrhage, shunt patency, encephalopathy and cumulative survival analysis. In a selected group of patients, hemodynamic measurements were also obtained in the pre, intra, and postoperative periods. These included measurements of wedged hepatic vein pressure, superior mesentric venous blood flow, and residual superior mesenteric, hepatic sinusoidal and inferior vena cava pressures following the shunt procedure. Additionally, direct shunt flow measurements utilizing a square wave of electromagnetic flowmeter were also performed. Results indicate that the shunt patency is 95%; adequate decompression of the portal system was accomplished; recurrent variceal hemorrhage did not occur if the shunt remained patent; the incidence of encephalopathy was low (11%); and the operative mortality for the entire series was 9%. Continued perfusion of the liver was documented in 44% of patients and appears to be a function of the residual total portal resistance largely controlled by inferior vena caval pressure at the level of graft replacement. Life survivhat the interposition mesocaval shunt appears to be an effective technique for the control of variceal hemorrhage, has important hemodynamic advantages and can be applied to most patients for the control of variceal hemorrhage due to portal hypertension.

Entities:  

Mesh:

Substances:

Year:  1975        PMID: 124159      PMCID: PMC1345527          DOI: 10.1097/00000658-197505000-00004

Source DB:  PubMed          Journal:  Ann Surg        ISSN: 0003-4932            Impact factor:   12.969


  18 in total

1.  THE IMPORTANCE OF HEMODYNAMIC STUDIES IN MANAGEMENT OF PORTAL HYPERTENSION.

Authors:  W D WARREN; J E RESTREPO; J C RESPESS; W H MULLER
Journal:  Ann Surg       Date:  1963-09       Impact factor: 12.969

2.  Critical comparative analysis of early and late results of splenorenal and direct portacaval shunts performed in 169 patients with portal cirrhosis.

Authors:  R R LINTON; D S ELLIS; J E GEARY
Journal:  Ann Surg       Date:  1961-09       Impact factor: 12.969

3.  Direct measurement of hepatic blood flow in surgical patients: with related observations on hepatic flow dynamics in experimental animals.

Authors:  W G SCHENK; J C McDONALD; K McDONALD; T DRAPANAS
Journal:  Ann Surg       Date:  1962-09       Impact factor: 12.969

4.  Interposition teflon mesenteric caval shunt for bleeding oesophageal varices.

Authors:  G R Giles; T G Brennan; M S Losowsky
Journal:  Br J Surg       Date:  1973-08       Impact factor: 6.939

5.  Selective distal splenorenal shunt. Technique and results of operation.

Authors:  W D Warren; A A Salam; D Hutson; R Zeppa
Journal:  Arch Surg       Date:  1974-03

6.  Portal-systemic shunt in hepatic cirrhosis: does the type of shunt decisively influence the clinical result?

Authors:  H Bismuth; D Franco; J Hepp
Journal:  Ann Surg       Date:  1974-02       Impact factor: 12.969

Review 7.  The role of hemodynamic measurements in portosystemic shunt surgery.

Authors:  T B Reynolds
Journal:  Arch Surg       Date:  1974-03

8.  The origin, hormonal nature, and action of hepatotrophic substances in portal venous blood.

Authors:  T E Starzl; A Francavilla; C G Halgrimson; F R Francavilla; K A Porter; T H Brown; C W Putnam
Journal:  Surg Gynecol Obstet       Date:  1973-08

9.  Proceedings: Interposition "H" grafting for protal hypertension.

Authors:  B W Thompson; R C Read
Journal:  Arch Surg       Date:  1974-04

10.  Interposition mesocaval shunt for treatment of portal hypertension.

Authors:  T Drapanas
Journal:  Ann Surg       Date:  1972-10       Impact factor: 12.969

View more
  22 in total

Review 1.  Portal hypertension--25 years of progress.

Authors:  B R MacDougall; D Westaby; L A Blendis
Journal:  Gut       Date:  1991-09       Impact factor: 23.059

2.  Mesocaval and distal splenorenal shunts: effect on hepatic function, hepatic hemodynamics, and portal systemic encephalopathy.

Authors:  R Herz; H J Halbfass; M Rössle; D Waldmann; W Gerok
Journal:  Klin Wochenschr       Date:  1985-05-02

3.  Portal pseudoperfusion: an angiographic illusion.

Authors:  J T Fulenwider; B M Nordlinger; W J Millikan; P J Sones; W D Warren
Journal:  Ann Surg       Date:  1979-03       Impact factor: 12.969

4.  A randomized, controlled trial of the distal splenorenal shunt.

Authors:  L F Rikkers; D Rudman; J T Galambos; J T Fulenwider; W J Millikan; M Kutner; R B Smith; A A Salam; P J Sones; W D Warren
Journal:  Ann Surg       Date:  1978-09       Impact factor: 12.969

5.  Selection of operation in patients with bleeding esophageal varices.

Authors:  B Langer; S C Patel; R M Stone; R F Colapinto; M J Phillips; M M Fisher
Journal:  Can Med Assoc J       Date:  1978-02-18       Impact factor: 8.262

6.  The Emory prospective randomized trial: selective versus nonselective shunt to control variceal bleeding. Ten year follow-up.

Authors:  W J Millikan; W D Warren; J M Henderson; R B Smith; A A Salam; J T Galambos; M H Kutner; J H Keen
Journal:  Ann Surg       Date:  1985-06       Impact factor: 12.969

7.  Risks in therapeutic portacaval and splenorenal shunts.

Authors:  R A Malt; J Szczerban; R B Malt
Journal:  Ann Surg       Date:  1976-09       Impact factor: 12.969

Review 8.  Portal circulation and portal hypertension.

Authors:  S Sherlock
Journal:  Gut       Date:  1978-01       Impact factor: 23.059

9.  Hepatic blood flow after canine portasystemic shunting.

Authors:  C H Shatney; J W Harmon; N M Rich
Journal:  Ann Surg       Date:  1982-08       Impact factor: 12.969

10.  Traumatic injuries of the portal vein. The role of acute ligation.

Authors:  H L Pachter; S Drager; N Godfrey; R LeFleur
Journal:  Ann Surg       Date:  1979-04       Impact factor: 12.969

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.